Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'pharmacogenomics' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 66 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Herrmann, JL; Rastelli, L; Burgess, CE; Fernandez, EE; Rothberg, BEG; Rothberg, JM; Shimkets, RA
      Implications of oncogenomics for cancer research and clinical oncology

      CANCER JOURNAL
    2. Weber, WW
      The legacy of pharmacogenetics and potential applications

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    3. Niculescu, AB; Akiskal, HS
      Proposed endophenotypes of dysthymia: evolutionary, clinical and pharmacogenomic considerations

      MOLECULAR PSYCHIATRY
    4. Beaudet, L; Bedard, J; Breton, B; Mercuri, RJ; Budarf, ML
      Homogeneous assays for single-nucleotide polymorphism typing using AlphaScreen

      GENOME RESEARCH
    5. Zhang, J; Kuehl, P; Green, ED; Touchman, JW; Watkins, PB; Daly, A; Hall, SD; Maurel, P; Relling, M; Brimer, C; Yasuda, K; Wrighton, SA; Hancock, M; Kim, RB; Strom, S; Thummel, K; Russell, CG; Hudson, JR; Schuetz, EG; Boguski, MS
      The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants

      PHARMACOGENETICS
    6. Baba, Y
      Development of novel biomedicine based on genome science

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    7. Weber, WW
      Effect of pharmacogenetics on medicine

      ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
    8. Saijo, N; Tamura, T; Yamamoto, N; Nishio, K
      New strategies for cancer therapy in the 21st century

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    9. Whitfield, GK; Remus, LS; Jurutka, PW; Zitzer, H; Oza, AK; Dang, HTL; Haussler, CA; Galligan, MA; Thatcher, ML; Dominguez, CE; Haussler, MR
      Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    10. Weinstein, JN
      Searching for pharmacogenomic markers: The synergy between omic and hypothesis-driven research

      DISEASE MARKERS
    11. Jiang, JD; Zhang, H; Li, JN; Roboz, J; Qiao, WB; Holland, JF; Bekesi, G
      High anticancer efficacy of L-proline-m-bis (2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride (MF13) in vivo

      ANTICANCER RESEARCH
    12. Guengerich, FP
      Functional genomics and proteomics applied to the study of nutritional metabolism

      NUTRITION REVIEWS
    13. Kennedy, MA
      What does the human genome project mean for medicine?

      NEW ZEALAND MEDICAL JOURNAL
    14. Bakhtiar, R; Nelson, RW
      Mass spectrometry of the proteome

      MOLECULAR PHARMACOLOGY
    15. Oliva, R
      Human genome: Genomics, genetics and medical applications

      MEDICINA CLINICA
    16. Charron, P; Komajda, M
      Are we ready for pharmacogenomics in heart failure?

      EUROPEAN JOURNAL OF PHARMACOLOGY
    17. Maimone, D; Dominici, R; Grimaldi, LME
      Pharmacogenomics of neurodegenerative diseases

      EUROPEAN JOURNAL OF PHARMACOLOGY
    18. Wieczorek, SJ; Tsongalis, GJ
      Pharmacogenomics: will it change the field of medicine?

      CLINICA CHIMICA ACTA
    19. Schmitz, G; Aslanidis, C; Lackner, KJ
      Pharmacogenomics: implications for laboratory medicine

      CLINICA CHIMICA ACTA
    20. Certa, U; Seiler, M; Padovan, E; Spagnoli, GC
      High density oligonucleotide array analysis of interferon-alpha 2a sensitivity and transcriptional response in melanoma

      BRITISH JOURNAL OF CANCER
    21. Levy, F
      Implications for australia of the multimodal treatment study of children with Attention-Deficit/Hyperactivity disorder

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    22. Zhang, S; Van Pelt, CK; Schultz, GA
      Electrospray ionization mass spectrometry-based genotyping: An approach for identification of single nucleotide polymorphisms

      ANALYTICAL CHEMISTRY
    23. Nakamura, K; Hanna, IH; Cai, HL; Nishimura, Y; Williams, KM; Guengerich, FP
      Coumarin substrates for cytochrome P450 2D6 fluorescence assays

      ANALYTICAL BIOCHEMISTRY
    24. Fagerlund, TH; Braaten, O
      No pain relief from codeine ...? An introduction to pharmacogenomics

      ACTA ANAESTHESIOLOGICA SCANDINAVICA
    25. Lanchbury, JS; Schork, NJ
      Peaks and troughs in linkage mapping for the rheumatic diseases

      RHEUMATOLOGY
    26. Tsongalis, GJ; Cartun, RW; Ricci, A
      Gene amplification as means for determining therapeutic strategies in human cancers

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    27. Siest, G; Bertrand, P; Herbeth, B; Vincent-Viry, M; Schiele, F; Sass, C; Visvikis, S
      Apolipoprotein E polymorphisms and concentration in chronic diseases and drug responses

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    28. Baudin, B
      Angiotensin I-converting enzyme gene polymorphism and drug response

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    29. Nebert, DW
      Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    30. Rininger, JA; DiPippo, VA; Gould-Rothberg, BE
      Differential gene expression technologies for identifying surrogate markers of drug efficacy and toxicity

      DRUG DISCOVERY TODAY
    31. Xu, JQ; He, XZ; Zhou, YX; Liu, LT; Cheng, J
      Research and applications of biochip technologies

      CHINESE SCIENCE BULLETIN
    32. Saunders, AM; Trowers, MK; Shimkets, RA; Blakemore, S; Crowther, DJ; Mansfield, TA; Wallace, DM; Strittmatter, WJ; Roses, AD
      The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
    33. Ferrari, P; Bianchi, G
      Genetic mapping and tailored antihypertensive therapy

      CARDIOVASCULAR DRUGS AND THERAPY
    34. March, R
      Pharmacogenomics: the genomics of drug response

      YEAST
    35. van Ommen, GJB
      Human genetics in health care

      EUROPEAN JOURNAL OF PEDIATRICS
    36. Moos, WH; Steliou, K
      Pharmacogenomics 2000

      DRUG DEVELOPMENT RESEARCH
    37. Kadens, DT; Le Gear, ML
      Pharmacogenomics: Into the new millennium

      DRUG DEVELOPMENT RESEARCH
    38. Attur, M; Bingham, CO; Dave, M; Abramson, SB; Amin, AR
      Model protocol to study pharmacogenomics in inflammatory diseases: Human rheumatoid arthritis

      DRUG DEVELOPMENT RESEARCH
    39. Paweletz, CP; Gillespie, JW; Ornstein, DK; Simone, NL; Brown, MR; Cole, KA; Wang, QH; Huang, J; Hu, N; Yip, TT; Rich, WE; Kohn, EC; Linehan, WM; Weber, T; Taylor, P; Emmert-Buck, MR; Liotta, LA; Petricoin, EF
      Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip

      DRUG DEVELOPMENT RESEARCH
    40. Liyanage, MS; Xanthopoulos, KG
      Human DNA sequence polymorphisms: New opportunities for drug discovery andcustomized patient care

      DRUG DEVELOPMENT RESEARCH
    41. Rothberg, BEG; Ramesh, TM; Burgess, CE
      Integrating expression-based drug response and SNP-based pharmacogenetic strategies into a single comprehensive pharmacogenomics program

      DRUG DEVELOPMENT RESEARCH
    42. Ilag, LL; Ng, JH; Jay, DG
      Chromophore-assisted laser inactivation (CALI) to validate drug targets and pharmacogenomic markers

      DRUG DEVELOPMENT RESEARCH
    43. Fijal, BA; Hall, JM; Witte, JS
      Clinical trials in the genomic era: Effects of protective genotypes on sample size and duration of trial

      CONTROLLED CLINICAL TRIALS
    44. Armstrong, B; Stewart, M; Mazumder, A
      Suspension arrays for high throughput, multiplexed single nucleotide polymorphism genotyping

      CYTOMETRY
    45. Topol, EJ
      The future of antiplatelet therapy: Optimizing management in patients withacute coronary syndrome

      CLINICAL CARDIOLOGY
    46. Tanaka, T; Nishimura, Y; Tsunoda, H; Naka, M
      Pharmacogenomics and therapeutic target validation in cerebral vasospasm

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    47. Cichon, S; Nothen, MM; Rietschel, M; Propping, P
      Pharmacogenetics of schizophrenia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    48. Nebert, DW; Dieter, MZ
      The evolution of drug metabolism

      PHARMACOLOGY
    49. Kimura, S; Gonzalez, F
      Applications of genetically manipulated mice in pharmacogenetics and pharmacogenomics

      PHARMACOLOGY
    50. Diasio, RB; Johnson, MR
      The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil

      PHARMACOLOGY
    51. Brockmoller, J; Cascorbi, I; Henning, S; Meisel, C; Roots, I
      Molecular genetics of cancer susceptibility

      PHARMACOLOGY
    52. Kawanishi, Y; Tachikawa, H; Suzuki, T
      Pharmacogenomics and schizophrenia

      EUROPEAN JOURNAL OF PHARMACOLOGY
    53. Lichtermann, D; Franke, P; Maier, W; Rao, ML
      Pharmacogenomics and addiction to opiates

      EUROPEAN JOURNAL OF PHARMACOLOGY
    54. Iwahashi, K; Anemo, K; Nakamura, K; Yoshihara, E; Igarashi, K
      Analysis of the metabolism of haloperidol (HP) and its neurotoxic pyridinium metabolite (HPP+) in patients with drug-induced parkinsonism

      CLINICA CHIMICA ACTA
    55. Griffin, TJ; Smith, LM
      Genetic identification by mass spectrometric analysis of single-nucleotidepolymorphisms: Ternary encoding of genotypes

      ANALYTICAL CHEMISTRY
    56. Johnson, MR; Wang, KS; Smith, JB; Heslin, MJ; Diasio, RB
      Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction

      ANALYTICAL BIOCHEMISTRY
    57. Cacabelos, R; Alvarez, A; Fernandez-Novoa, L; Lombardi, VRM
      A pharmacogenomic approach to Alzheimer's disease

      ACTA NEUROLOGICA SCANDINAVICA
    58. Gomez-Sancha, F
      BPH in the next millennium: a glimpse to the future

      PROSTATE CANCER AND PROSTATIC DISEASES
    59. Hess, P; Cooper, D
      Impact of pharmacogenomics on the clinical laboratory

      MOLECULAR DIAGNOSIS
    60. Shi, MM; Bleavins, MR; de la Iglesia, FA
      Technologies for detecting genetic polymorphisms in pharmacogenomics

      MOLECULAR DIAGNOSIS
    61. Anderson, WH; Fitzgerald, CQ; Manasco, PK
      Current and future applications of pharmacogenomics

      NEW HORIZONS-THE SCIENCE AND PRACTICE OF ACUTE MEDICINE
    62. Wilgenbus, KK; Lichter, P
      DNA chip technology ante portas

      JOURNAL OF MOLECULAR MEDICINE-JMM
    63. Kuhlmann, J
      Alternative strategies in drug development: clinical pharmacological aspects

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    64. Pratt, RE; Dzau, VJ
      Genomics and hypertension - Concepts, potentials, and opportunities

      HYPERTENSION
    65. Williams, KL
      Genomes and proteomes: Towards a multidimensional view of biology

      ELECTROPHORESIS
    66. ZUHLSDORF MT
      RELEVANCE OF PHENO-TYPING AND GENOTYPING IN CLINICAL DRUG DEVELOPMENT

      International journal of clinical pharmacology and therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 22:40:34